A Phase 3 Open-label Extension Study to Investigate the Long-term Safety and Efficacy of Orally Administered NNZ-2591 in Pediatric Participants with Phelan McDermid Syndrome NEU-2591-PMS-302
Researcher(s)
Ontario Location
Holland Bloorview Kids Rehabilitation Hospital | Toronto, Ontario, Canada, M4G 1R8
